Open AccessBorderline Resectable Pancreatic Cancer: On the Edge of Survival
Author(s) -
Gregory M. Springett,
Sarah E. Hoffe
Publication year - 2008
Publication title -
cancer control
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.794
H-Index - 72
eISSN - 1526-2359
pISSN - 1073-2748
DOI - 10.1177/107327480801500404
Subject(s) - medicine , pancreatic cancer , gemcitabine , radiation therapy , chemoradiotherapy , oncology , neoadjuvant therapy , chemotherapy , pancreas , cancer , radiology , breast cancer
Patients with borderline resectable pancreatic cancer are at high risk of having positive surgical margins due to involvement of the tumor with adjacent vasculature. This article reviews the management of this subset of pancreatic cancer patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom